Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New breast cancer study findings have been published by scientists at University of Toronto
November 20th, 2008
" Hormone therapy (HT) is commonly given to women to alleviate the climacteric symptoms associated with menopause. There is concern that this treatment may increase the risk of breast cancer," scientists writing in the Journal of the National Cancer Institute report. "The potential association of HT and breast cancer risk is of particular interest to women who carry a mutation in BRCA1 because they face a high lifetime risk of breast cancer and because many of these women take HT after undergoing prophylactic surgical oophorectomy at a young age. We conducted a matched case-control study of 472 postmenopausal women with a BRCA1 mutation to examine whether or not...
Source: Women's Health Weekly (2008-11-20)
|
